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B 16 melanoma (mouse melanoma) and C24 melanoma 
(huma n m a lignant melanoma) transplanted in mice were 
treated b y a combined therapy of ACNU [1-(4-amino-2-
methyl- 5- p y rimidiny l) - methyl - 3 - (2 - chlorethyl) -
3 - nitrosourea hydrochloride] (10 mgjkg) and hyper-
t he rmia (43°C , 30 min) . In both types of melanoma, a 
mark ed synergistic effect of the combined therapy was 
noted. Particularly in C2 4 melanoma a reduction in the 
size of tumor w as observed. Histopathologic findings 
re vealed a strong degeneration such as destruction of 
the tumor s t ructure and vacuolization of nuclei. 
ln 1960 W oodha ll eL a l [l] used a combined t he rapy o f 
hyperthe rmi a a nd a n t it umo r agen ts in squa mous cell carci-
noma, a nd noted t he e ffective ness o f t he combined t he ra py. In 
t he 1970s, expe rime ntal studies o n the actio n o f a n t it um or 
agents a nd hyperthe rmia in va rious kinds o f t umor ce ll s cu l-
tured in v it ro we re r epo rted [2- 4 ]. Curre n t ly it is known t hat 
t he re are severa l kinds o f a n t it umo r age nts [ 4- 6 ] whi c h exer t 
a n en h a n ced actio n in co mbinatio n wit h t he use of hyp ert he r-
mia. Am o n g t he m a re ni t rosourea de rivatives s uch as BCNU 
[1,3 -bis-(2 -c hl o roethy l)- l -ni t rosourea ] or CC NU [l - (2-c h loroe-
t hy l) -(3-cyc lo hexy l)- 1-ni t rosou rea ] w it h which a synergistic e f-
fect has been p roved in a nima l experiments (7,8]. 
ACNU [1 -(4-amino-2- methy l-5 -p yrimidiny l)methy l-3- (2-
c hl orethy l ) -~~- ni trosourea hydrochl o ride] [9] is a water -solubl e 
ni t rosourea de rivat ive developed in J a pa n . In the prese n t e x-
pe rime n t we used the AC N U t her a py in com b inatio n wit h 
hype rt herm ia in mice, a nd it p roved to have a m a rked sy ne r-
gistic e ffect. 
M ATERI A LS AN D MET HODS 
8 16 Melanoma 
Animals: C57BL/6 male mice, 6- 8 weeks of age, were purchased 
from Nippon Seibu tsuzairyo Co. and bred under SPF experimenta l 
facilit ies. 
Tumo rs: B 16 melanoma supplied by the National Cancer Cente r was 
subcultured and t hen subcutaneously t ra nsplanted at a rate of 10n cells 
per 0.1 ml in the dorsal s ide of the femoral root of mice. T he tumors 
showed a 100 % take and reac hed 500- 700 mm" about 14 clays a fte r 
tra nsplantation, when t he experiment was started. Those t ransplanted 
tumors that proliferated wit h subcutaneous infi lt ration or beca me 
obscure or irregu lar in shape were excluded from the experiment. 
Dru.g: ACNU was supplied by the San kyo Co. The drug was kept in 
a da rk environment and dissolved in distilled water before injection. 
In a concentra tion of 10 mg/kg it was administered i.p. every other 
day, for a tota l of 3 ti mes. 
Manuscript received July 13, 1983; accepted for publ ication Septem-
ber 14 , 1983. 
Rep rin t requests to: Kiyoshi Yamada, M.D., Depar tment of Der-
matology, Facul ty of Medicine, Unive rsity of T okyo, T okyo, Japan. 
Abbrev iations: 
ACNU: 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3- (2-chlo-
roethyl) -3- n it rosourea hydroc hloride 
BCN U: 1,3-bis-(2-c hloroethy I )- 1-n it rosourea 
CCNU: 1-(2-chloroethyl) -(3-cyclohexyl) -1-ni t rosourea 
T/C: relative max imal suppression rate of tumor 
Topical heating: A T -80 thermostat (T okyo Rika Co.) was used fo r 
topical heating. A digital thermometer (Baily Co.) was used for meas-
urement of temperature. The temperature of t he water bath was sta-
bilized at 43.5•C ± 0.1. Fig 1 shows the cha nges of temperature in each 
site with t ime during topical heating. Immediate ly afte r ACN U admin -
istration, the animals were anesthetized wi t h i.p. administration of 
Ketamine hydrochloride (Ketamine) 3 mg/kg and t hen soaked in a 
wate r bath. In view of possible undesirable effects of Ketamine on t he 
animals, the same dose was administered i.p. to a ll the anima ls. 
C24 Melanoma. 
AnirnaL5: Male BALB/c-nu mice, 5- 7 weeks old, purchased from t he 
Nippon Clea Co., were used in the experiment. The anima ls were bred 
under SPF fac ilities using sterili zed aluminium gauge and fil ter cap 
and were give n ""Co-irradiated feed and city wate r sterili zed by high: 
pressure steam. 
Tumors: C24 melanoma supplied by t he National Ca ncer Ce nte r was 
subcul tured and subcutaneously t ra nspla nted at a rate of 106 cells per 
0. 1 ml in the femoral root of mice. The tumors grew to a size of 1000-
1300 mm" about 60 days a fter transplanta t ion, when the tumors were 
sterilely isolated, cut in to 2- mm" pieces, and subcutaneously trans-
pla nted by a t rocar in t he dorsa l side of the femoral root of the mice. 
"Drug" and "topica l heating" were the sa me as in 8 16 mela noma. 
Evaluation of T u.rnors 
T umor growth curve: Tumors in each anim al group were measured 
hy slide callipers at least twice a week to calculate the tumor volume 
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topical heatin g. The temperature of in tratumor reaches a level of 43 · c 
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us ing t he following formula: 
a x b2 
2 
w h ere a = long di ameter a nd b = short diameter. 
Wi th the mean volume of the tumors in each group, a tumor growt h 
cur ve of each group was obta ined. 
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FIG 2. Experiment A. Tumor growt h curves. No growt h of tumors 
was observed for a period of 18 days a fter t he ini t ia l t rea tment . Bar = 
SE; arrows = treatment; g refe rs to weight of anima ls. 
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F I G 3. Experiment B . Tumor growth curves. ACN U + heat group 
showed a marked a nti tumor effec t compared wi t h the ACNU group. 
Bar = SE; arrows = treatment, g refers to weight of animals. 
TABLE I. T umor growth delay and mouse survival 
81 6 melanoma 
Tumor growt.h Median day of 
delay" (days) death (days) 
Exp. A Exp. B Exp. A Exp. B 
Cont rol 0 0 so± 1s.o• 28 ± 9.6 
ACNU 5 2 43 ± 19.8 42 ± 18.1 
ACNU +heat 19 16 51 ± 19.5 53 ± 19.9 
Heat 1 2 28 ± 10.0 31 ± 8.4 
" Tumor growt h delay was determined on t he day the ave rage vo lu me 
of the cont rol t umor fi rst exceeded 10 em'. 
• Average± SD. 
TABLE II. Relative maximal suppression rate of the tumor (T/C) 
816 melanoma( %) 
ACNU 
ACNU +heat 
Heat 
C24 melanoma( %) 
ACNU 
ACNU + heat 
Heat 
Exp.A 
40.2 (+ ) 
10.7 (+ )" 
70 (-) 
27 (+ ) 
5.3 (++ )" 
53(-) 
"Significant ly d ifferent from cont rols, p < 0.01 . 
1
' Significantly different from cont rols, p < 0.05. 
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FIG 4. C24 melanoma. Tumor growth curves. In the ACNU + heat. 
group the tumor growth was completely suppressed a fter the second 
treatment and the mea n volume of the tumor shows a decreasing t rend. 
Bar = SE; arrows= t reatmen t.. g refers to weight of animals. 
Rela tive maximal suppression rate of tumor (T / C): T he max imal 
va lue of T /C was obtained by t he following formula: 
Tn / Cn . 00 - -X l 
T o Co 
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where Tn = tumor volume of day n in treated group, To = tumor 
volume of day 0 in t reated group, Cn = tumor volume of day n in 
control group , and Co= tumo r volume of day 0 in control group. 
Histopathology: Only C24 melanoma was exam ined in the present 
expe riment. The tumors from each group we re isolated at day 7 afte r 
fina l t reatment and im med iate ly fixed with forma lin . Hematoxylin a nd 
eosin-stained tu mor ce lls were submi tted for light microscopic exami-
nation. 
Mouse suruiual (median day of death): Only animals t ransplanted 
with 816 melanoma were exa mined. The animals t hat died in the 
course of t he exper iments as well as t hose that died by day 2 a fter the 
fin al t reatment we re excluded from calcu la tion s of the surviva l. The 
median day of death was expressed as the average of each group 's 
pe riod from initial treatment to the date of death. 
RESULTS 
B/6 Melanoma 
The expe riment was carried out twice (experiments A and 
B). The tumo rs from eac h gro up were sampled random ly. 
Tumor growth curve (Figs 2, 3): Tumors from the control 
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grou p and t he heat gro up in expe rime n ts A and B inc reased 
nearly in para ll e l a nd grew to 10,000 mm" in approximately 14 
days after t reatmenl. In t he ACNU group, t um or growth rate 
was lowe red a fte r the first treatment as compared with t h e 
control group ; t hus, a n obvious a n t it umor effect was noted. 
The ACNU + heat group s howed a more m a rked a n t it umor 
e ffect in both experime n ts A a nd B. T he growth of t umors was 
nearly com pletely s uppressed afte r t he t hird treatmenl. Espe-
c ia lly in expe riment A, no growth o f tumors was observed fo r a 
period o f about 18 days after t he t reatm e n t was started, d em-
o nstrati ng a n exce ll ent inhibiting effecl. In tumor growth delay, 
t he ACNU + heat group s howed prolo ngatio ns o f abou t 17 days 
and 14 days as compared with t he contro l group a nd the ACNU 
group, respectively (Table 1). 
Relative maximal suppression. rate of tumor (T/C): T /C in 
eac h group is s how n in Table II. No t herapeutic effect was 
obse rved in the heat group, while in t he ACNU group s howi n g 
40.2% a nd 35% a s light effect was noted. In the ACNU + h eat 
group, T/C was less than 10% in both experime n ts A and B , 
y ie ldin g a noticeable antitumor e ffect. 
FIG 5. C24 melanoma. Hematoxylin a nd eosin -stained biopsy specimens obtained from the tumors at day 7 afte r the final t reatment. A, 
ACNU + heat group, showing the ent ire subcutaneous tumor. Partial destruction of the tumor structure is recognized (arrow). B, ACNU + hear 
group. Marked vacuolization of nuclei of tumor cells is seen (a rrows). C, ACNU + heat group. Degenerated tumor ce lls remain within the 
surroundin g fibrous tissue of tumor (arrows) . D, Tumor cells of the cont rol group. 
Feb. 1984 THERMOCHEMOTHERAPY FOR MALIGNANT MELANOMA 183 
Mouse survival: As shown in Table I, the ACNU + heat 
group showed prolongations of about 23 days and 10 days as 
compared with t he control group and ACNU group, respec-
tively. There was no app rec iab le difference between the heat 
group and the cont rol group. 
C24 Melanoma 
The experiment was done usi ng animal groups each consist-
ing of 5 mice. The t umors of each group were s imilar in size 
(70-180 mm") at day 14 after transp lantation and were ran -
domly selected. After the topical heating, al l the animals of 
each group survived with less than 10% loss in body weight. 
Tumor growth curve: Fig 4 shows the tumor growth curve of 
each group. Tumors of both cont rol and heat groups showed a 
s imila r growth rate, as in 816 melanoma, and reached 1000 
mm'1 about day 28. In t he ACNU group, t he growth rate declined 
immediately after t he final treatment and tumor growth was 
nearly suppressed up to about day 12. Thereafter, t his group 
again showed an upward tumor growth, with no appreciable 
difference from the contro l group. On t he other hand, in the 
ACNU + heat group the tumor growth was completely sup-
pressed after t he second treatment and the mean volume of the 
tumors showed a decreasing trend. 
Relative maximal suppression ra te of tumor (T/C) (Table !1): 
A T /C of less t ha n 42% was obtained in t he ACNU group; this 
indicates t hat ACNU alone cou ld yield a certain degree of 
therapeutic effect on C24 melanoma. On the other hand, in t he 
ACNU + heat group, which showed a reduction in size of each 
tumor, an excellent T/C of 5.3% was obtained; it was t hus 
confirmed that t he combined t herapy had a powerful anti tumor 
effect. 
Histopathology: In t he ACNU + heat group, tumors showing 
a reduction in s ize were iso lated and submi tted for his to logic 
examination. The subcutaneous tumor was composed of rich 
fibrous tissue as well as tumor ce ll s of t he central part (Fig 
SA). In t umor cells, vacuolization of nuclei was remarkab le (Fig 
5B ). Some tumo r ce lls remained with in t he fibrous tissue and 
partial destruction of t he tumor structure was noted, as shown 
in Fig 5C. Fig. 5D shows the tumor ce lls of the control group. 
Fig 6 shows a tumor growth curve on C24 me lanoma obtained 
after t he first course of treatment and also when the second 
course was started on t he 12th day. Each tumor tended to 
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F I G 6. Tumor growth curve of ACNU + heat group obtained at the 
second treatment of C24 melanoma. Each tumo r shows a marked 
reduction during the second course of t.reat.ment. Bar= SE; arrow~ = 
treatment. 
reduce noticeably after t he second course. On day 60 after 
initial treatment, no regrowth of the tumors of 2 mice was 
observed. A histo logic spec imen of t he tumor showed that t he 
tumor structure was replaced by rich fibrous tissue and no 
tumor cell was recognized. 
DISCUSSION 
The combined use of hyperthermia and a lkylating agents of 
nitrosoureas such as BCNU, CCNU, and Me-CCNU was at-
tempted by Hahn [10] in 1978, who noted a synergistic effect 
of t he combined therapy. A s imilar synergistic effect has been 
confirmed by Marmor [7] and Twentyman et al [8] in their 
an imal experiments. ACNU , a water-soluble ni trosou rea devel-
oped in Japan, is known to show a powerful a ntitu mor effect 
on various kinds of tumor ce lls [1 2,13] in animal experiments 
including mouse leukem ia L-1210 [11]. This agent has been 
used clin ically for the treatment of cerebral tumor [1 4], cancer 
of t he digestive system [1 5], lung cancer (16], leukemia [17], 
etc., and favorable resu lts have been obtained. In malignant 
melanoma, a synergistic effect of ACNU combined with an 
antimetaboli te has been recognized in animal experiments [18] 
using B16 melanoma. Clinica lly, it has also been reported [19] 
t hat ACNU in combined use with such agents as vincristine or 
vinblastine proved effective. However, in Western countries 
where hyperthermia is used, there have been no reports on t he 
combination therapy of ACNU and hype rthermia, probably 
because ACNU has not yet been made avai lable there. 
In the present experiment, a complete suppression of the 
tumor growth for a period of more t han 2 weeks of treatment 
in 816 mela noma (mouse melanoma) as well as a reduction of 
t he tumor vo lume in C24 me lanoma (human malignant mela -
noma) were obse rved. Thus, it was confirmed that combination 
t herapy of hyperthermia (43'C, 30 min) and ACNU (10 mg/ 
kg) has a powerful antitumor effect due to t heir synergistic 
action . Further, histopathologic findings revealed destruction 
of the tumor structure and marked vacuo li zation of nuclei in 
the residua l tu mor ce lls. Consequently it can be considered t hat 
an excellent therapeutic effect of the combined therapy has 
also been confirmed histologica lly. 
The present expe riment was ca rried out in accordance with 
t he protocol under which one course consisted of t reatment 
every other day for a total of 3 times. It is expected t hat further 
repeated treatments will yield a more remarkable antitumor 
effect. The mean volume of the tumors of the ACNU + heat 
group obtai ned at the second treatment of C24 melanoma 
showed a ma rked reduction. On day 36 after initial t reatment, 
the tumors of 2 mice were too small to measure. As of day 60, 
no regrowth of tumors was observed. Furthermore, a histologic 
spec imen of the tumor showed replacement by rich fibrous 
t issue without tumor ce ll. T he increased antitumor effect 
proved by means of such repeat treatment seems of in terest for 
clinical application. 
The mechanism of interaction between hyperthermia and 
ant itumor agents is different depending on t he agent used . 
Possible exp la nations include an increased intracellular con-
centrat ion of t he a ntitumor agent through its increased mem -
brane trans it [4] or its inhibi tion of the repair of cell damages 
[20 1; however, further investigation is indicated for full eluci-
dation of t he mechanism involved. It is expected t hat with 
further improvement of t hermomachinery, combined therapy 
wi!.h antitumor age nts including ACNU reported here will yield 
fruitful resul ts in clinical app lication. 
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